This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove abortion
Remove 2019 Remove Patients Related Topics
Epilepsy Clinical Trials Treatment Conditions Access Programs Chronic Pain Decriminalization Seed-To-Sale Data More Related Topics >
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3%

Terpenes 132
Terpenes Strains THC Treatment 132
article thumbnail

Is Europe falling behind?

The Cannigma

MAY 7, 2021

Also, in our new segment, “Nuggs of Wisdom,” we hear from senior Cannigma writer Ben Hartman about a rapidly aborted snortable cannabis product that hit the market this month, and what the science says about putting cannabis powder up your nose. Executive producer, Michael Schaeffer Omer-Man.

Supply Chain 120
Supply Chain Patients Access Hemp 120
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024